Home - Products - Others - Other Targets - Growth Hormone Releasing Factor, GRF (1 - 44), amide, bovine

Growth Hormone Releasing Factor, GRF (1 - 44), amide, bovine

CAS No. ———

Growth Hormone Releasing Factor, GRF (1 - 44), amide, bovine( ——— )

Catalog No. M41190 CAS No. ———

Growth Hormone Releasing Factor, GRF (1 - 44), amide, bovine

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Growth Hormone Releasing Factor, GRF (1 - 44), amide, bovine
  • Note
    Research use only, not for human use.
  • Brief Description
    Growth Hormone Releasing Factor, GRF (1 - 44), amide, bovine
  • Description
    Growth Hormone Releasing Factor, GRF (1 - 44), amide, bovine
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    5107.88
  • Molecular Formula
    C220H366N72O66S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Cap-dependent endonu...

    Cap-dependent endonuclease-IN-1 is a highly potent, orally active cap-dependent endonuclease inhibitor with antiviral activity for studying influenza virus infection.

  • AP39 Free base

    AP39 free base is a mitochondrial-targeted H(2)S donor that can improve the survival rate of porcine islets in culture.

  • Amylin (8-37) (human...

    Amylin (8-37), human is a fragment of human Amylin. Amylin (8-37), human has direct vasodilator effects in the isolated mesenteric resistance artery of the rat. Human Amylin is a small hormone secreted by pancreatic β-cells that forms aggregates under insulin deficiency metabolic conditions, and it constitutes a pathological hallmark of type II diabetes mellitus.